Trials / Not Yet Recruiting
Not Yet RecruitingNCT07229534
Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes
A Phase IV Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 238 (estimated)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, double-blind, active-controlled, randomized, parallel, phase IV clinical trial to evaluate the efficacy and safety of DA-5218 in patients with type 2 diabetes who have inadequate glycemic control with metformin
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-5218 | DA-5218 + DA-5218-C placebo |
| DRUG | DA-5218-C | DA-5218-C + DA-5218 placebo |
Timeline
- Start date
- 2025-11-01
- Primary completion
- 2027-11-01
- Completion
- 2027-11-01
- First posted
- 2025-11-17
- Last updated
- 2025-11-17
Source: ClinicalTrials.gov record NCT07229534. Inclusion in this directory is not an endorsement.